350 related articles for article (PubMed ID: 14628953)
1. Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.
Keiser PB; Coulibaly YI; Keita F; Traore D; Diallo A; Diallo DA; Semnani RT; Doumbo OK; Traore SF; Klion AD; Nutman TB
Am J Trop Med Hyg; 2003 Sep; 69(3):331-5. PubMed ID: 14628953
[TBL] [Abstract][Full Text] [Related]
2. The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.
Simonsen PE; Magesa SM; Dunyo SK; Malecela-Lazaro MN; Michael E
Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):462-72. PubMed ID: 15186934
[TBL] [Abstract][Full Text] [Related]
3. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.
Kyelem D; Sanou S; Boatin B; Medlock J; Coulibaly S; Molyneux DH
Ann Trop Med Parasitol; 2003 Dec; 97(8):827-38. PubMed ID: 14754495
[TBL] [Abstract][Full Text] [Related]
4. Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.
Dembele B; Coulibaly YI; Dolo H; Konate S; Coulibaly SY; Sanogo D; Soumaoro L; Coulibaly ME; Doumbia SS; Diallo AA; Traore SF; Diaman Keita A; Fay MP; Nutman TB; Klion AD
Clin Infect Dis; 2010 Dec; 51(11):1229-35. PubMed ID: 21039220
[TBL] [Abstract][Full Text] [Related]
5. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
Addiss DG; Beach MJ; Streit TG; Lutwick S; LeConte FH; Lafontant JG; Hightower AW; Lammie PJ
Lancet; 1997 Aug; 350(9076):480-4. PubMed ID: 9274584
[TBL] [Abstract][Full Text] [Related]
6. Higher-dose, more frequent treatment of Wuchereria bancrofti.
Kazura JW
Clin Infect Dis; 2010 Dec; 51(11):1236-7. PubMed ID: 21039221
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Edi C; Bjerum CM; Ouattara AF; Chhonker YS; Penali LK; Méité A; Koudou BG; Weil GJ; King CL; Murry DJ
PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of doxycycline for Mansonella perstans infection.
Coulibaly YI; Dembele B; Diallo AA; Lipner EM; Doumbia SS; Coulibaly SY; Konate S; Diallo DA; Yalcouye D; Kubofcik J; Doumbo OK; Traore AK; Keita AD; Fay MP; Traore SF; Nutman TB; Klion AD
N Engl J Med; 2009 Oct; 361(15):1448-58. PubMed ID: 19812401
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
Yongyuth P; Koyadun S; Jaturabundit N; Sampuch A; Bhumiratana A
J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blind field trial of ivermectin alone and in combination with albendazole for the treatment of Mansonella perstans infections in Uganda.
Asio SM; Simonsen PE; Onapa AW
Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):274-9. PubMed ID: 19081121
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.
Turner JD; Mand S; Debrah AY; Muehlfeld J; Pfarr K; McGarry HF; Adjei O; Taylor MJ; Hoerauf A
Clin Infect Dis; 2006 Apr; 42(8):1081-9. PubMed ID: 16575724
[TBL] [Abstract][Full Text] [Related]
12. Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
Wkly Epidemiol Rec; 2003 Sep; 78(36):315-7. PubMed ID: 14518107
[No Abstract] [Full Text] [Related]
13. Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment.
Dunyo SK; Nkrumah FK; Simonsen PE
Trans R Soc Trop Med Hyg; 2000; 94(4):437-43. PubMed ID: 11127253
[TBL] [Abstract][Full Text] [Related]
14. Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
Sahoo PK; Satapathy AK; Michael E; Ravindran B
Am J Trop Med Hyg; 2005 Nov; 73(5):877-80. PubMed ID: 16282297
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled clinical trial of increased dose and frequency of albendazole and ivermectin on Wuchereria bancrofti microfilarial clearance in northern Malawi.
Tafatatha TT; Ngwira BM; Taegtmeyer M; Phiri AJ; Wilson TP; Banda LG; Piston WN; Koole O; Horton J; French N
Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):393-9. PubMed ID: 25877874
[TBL] [Abstract][Full Text] [Related]
17. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.
Dunyo SK; Nkrumah FK; Simonsen PE
Trans R Soc Trop Med Hyg; 2000; 94(2):205-11. PubMed ID: 10897370
[TBL] [Abstract][Full Text] [Related]
19. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
[TBL] [Abstract][Full Text] [Related]
20. Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations.
Shenoy RK; John A; Babu BS; Suma TK; Kumaraswami V
Ann Trop Med Parasitol; 2000 Sep; 94(6):607-14. PubMed ID: 11064762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
